With 35+ lectures, a NASA keynote, and a river cruise through historic Heidelberg, this year’s symposium blends science and ...

The gift will be used to treat and potentially cure eye diseases like macular degeneration and glaucoma, increase focus on ...

TGFBI corneal dystrophy is a group of genetic eye disorders caused by mutations in the TGFBI gene, resulting in abnormal ...

Mark Daly discusses the transformative role of AI in ophthalmology, highlighting its potential to enhance patient care and ...

Jay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and ...

The TEASE-1 trial reveals gildeuretinol's potential to reduce vision loss in Stargardt disease, offering hope for future ...

On the heels of its FDA approval, clinicians weigh in on acoltremon’s (Tryptry) novel mechanism of action and its potential ...

The ELEVATUM study explored faricimab's effectiveness in treating diabetic macular edema among underrepresented minorities, ...

Researchers share that perfluorohexylactane eye drops offer rapid relief for dry eye disease, enhancing patient comfort ...

A study reveals attrition rates in geographic atrophy patients on complement inhibitor therapies, highlighting the need for ...

Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, ...

VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the ...